Document 0623 DOCN M9480623 TI Rhodococcus equi: first case in a heart transplant recipient. DT 9410 AU Segovia J; Pulpon LA; Crespo MG; Daza R; Rodriguez JC; Rubio A; Serrano S; Carreno MC; Varela A; Aranguena R; et al; Heart Transplant Unit, Clinica Puerta de Hierro, Madrid, Spain. SO J Heart Lung Transplant. 1994 Mar-Apr;13(2):332-5. Unique Identifier : AIDSLINE MED/94304903 AB Rhodococcus equi is a gram-positive diphtheroid that occasionally affects immunocompromised patients, usually causing a chronic respiratory infection with cavitating pulmonary opacities on chest radiograph that resemble mycobacterial or fungal disease. Etiologic diagnosis presents a number of pitfalls, because Rhodococcus equi isolates mimic many of the characteristics of other microorganisms more familiar to the laboratory staff. The treatment of choice for this disease has not yet been established, and its mortality rate is greater than 50% in individuals with human immunodeficiency virus and 20% to 25% among the remaining patients. We describe here the first case of Rhodococcus equi infection in a heart transplant recipient. Clinical presentation was typical, and treatment with a sensitivity-based combination of antibiotics resulted in resolution of both the clinical and radiologic picture. DE Adult Antibiotics, Combined/THERAPEUTIC USE Case Report Heart Transplantation/*IMMUNOLOGY Human Immunosuppressive Agents/ADMINISTRATION & DOSAGE/ADVERSE EFFECTS Male Microbial Sensitivity Tests Myocardial Diseases/IMMUNOLOGY/*SURGERY Opportunistic Infections/DRUG THERAPY/*IMMUNOLOGY Pneumonia/*IMMUNOLOGY Postoperative Complications/DRUG THERAPY/*IMMUNOLOGY Rhodococcus equi/DRUG EFFECTS/*IMMUNOLOGY Septicemia/*IMMUNOLOGY JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).